Epstein Secrets

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an

allICI11% IA") S0 Partial period adjustment (B-A,C) $13,460 10) DISCOUNT RATE The discount rate was estimated based on the weighted average cost Dr capital CWACC') for the Company as 01 the Valuation Date. We incorporated an additional risk premium to Felled the risk or achieving the threaded economics. Concl

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an

allICI11% IA") S0 Partial period adjustment (B-A,C) $13,460 10) DISCOUNT RATE The discount rate was estimated based on the weighted average cost Dr capital CWACC') for the Company as 01 the Valuation Date. We incorporated an additional risk premium to Felled the risk or achieving the threaded economics. Concl

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an

allICI11% IA") S0 Partial period adjustment (B-A,C) $13,460 10) DISCOUNT RATE The discount rate was estimated based on the weighted average cost Dr capital CWACC') for the Company as 01 the Valuation Date. We incorporated an additional risk premium to Felled the risk or achieving the threaded economics. Concl